Oddo BHF Asset Management Sas Purchases Shares of 8,191 CME Group Inc. $CME

Oddo BHF Asset Management Sas purchased a new stake in CME Group Inc. (NASDAQ:CME) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 8,191 shares of the financial services provider’s stock, valued at approximately $2,237,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Empowered Funds LLC lifted its stake in shares of CME Group by 11.5% in the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after acquiring an additional 1,037 shares during the period. Marshall Wace LLP lifted its stake in shares of CME Group by 103.1% in the second quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock worth $1,018,000 after acquiring an additional 121,707 shares during the period. Federated Hermes Inc. lifted its stake in shares of CME Group by 1,325.2% in the second quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock worth $6,497,000 after acquiring an additional 21,918 shares during the period. Nebula Research & Development LLC acquired a new position in shares of CME Group in the second quarter worth approximately $992,000. Finally, The Manufacturers Life Insurance Company lifted its stake in shares of CME Group by 2.6% in the second quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock worth $79,344,000 after acquiring an additional 7,397 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Down 1.7%

CME Group stock opened at $261.60 on Wednesday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 12-month low of $244.56 and a 12-month high of $329.16. The firm’s fifty day moving average is $283.14 and its 200 day moving average is $287.95. The company has a market capitalization of $94.79 billion, a PE ratio of 22.32, a PEG ratio of 2.97 and a beta of 0.21.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The company had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter in the previous year, the company earned $2.80 EPS. CME Group’s quarterly revenue was up 14.5% compared to the same quarter last year. As a group, sell-side analysts predict that CME Group Inc. will post 12.28 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Tuesday, June 9th. CME Group’s payout ratio is presently 44.37%.

Insiders Place Their Bets

In related news, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction on Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the transaction, the insider owned 27,702 shares in the company, valued at $8,438,860.26. The trade was a 17.20% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the transaction, the chief executive officer owned 55,630 shares in the company, valued at $16,606,111.30. The trade was a 38.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by insiders.

Analyst Ratings Changes

CME has been the topic of a number of recent analyst reports. Barclays cut their price objective on CME Group from $343.00 to $316.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 23rd. Jefferies Financial Group dropped their target price on shares of CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a report on Thursday, April 9th. Deutsche Bank Aktiengesellschaft decreased their price target on CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a report on Thursday, April 23rd. TD Cowen decreased their price target on CME Group from $340.00 to $323.00 and set a “buy” rating for the company in a report on Thursday, April 23rd. Finally, Morgan Stanley decreased their price target on CME Group from $362.00 to $353.00 and set an “overweight” rating for the company in a report on Thursday, April 23rd. Eleven equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $305.71.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.